Cargando…
Perilipin 5 and Lipocalin 2 Expression in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is one of the most prevalent and deadly cancers worldwide. Therefore, current global research focuses on molecular tools for early diagnosis of HCC, which can lead to effective treatment at an early stage. Perilipin 5 (PLIN5) has been studied as one of the main protein...
Autores principales: | Asimakopoulou, Anastasia, Vucur, Mihael, Luedde, Tom, Schneiders, Silvia, Kalampoka, Stavroula, Weiss, Thomas S., Weiskirchen, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468921/ https://www.ncbi.nlm.nih.gov/pubmed/30893876 http://dx.doi.org/10.3390/cancers11030385 |
Ejemplares similares
-
Deletion of Perilipin 5 Protects against Hepatic Injury in Nonalcoholic Fatty Liver Disease via Missing Inflammasome Activation
por: Asimakopoulou, Anastasia, et al.
Publicado: (2020) -
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
por: Asimakopoulou, Anastasia, et al.
Publicado: (2016) -
Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights
por: Mass Sanchez, Paola Berenice, et al.
Publicado: (2021) -
Mouse models of hepatocarcinogenesis: What can we learn for the prevention of human hepatocellular carcinoma?
por: Vucur, Mihael, et al.
Publicado: (2010) -
A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
por: Krizanac, Marinela, et al.
Publicado: (2021)